| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4168042 | The Journal of Pediatrics | 2007 | 4 Pages |
Abstract
BH4 responsiveness is more prevalent than was previously assumed, particularly in patients with mild hyperphenylalaninemia and mild PKU. Depending on the severity of hyperphenylalaninemia, selection criteria for the potential treatment with BH4 may range from 20% to 40% blood phenylalanine reduction after 24 hours.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Betina MD, Nenad PhD,